Endologix Buys Venture-backed Nellix
Publicly traded Endologix has acquired venture-backed medical device company Nellix Endovascular for $15 million in stock, plus additional milestone-based stock payments totaling as much as $39 million. As part of the acquisition, Nellix’s majority investor, Essex Woodlands Health Ventures, will also invest $15 million in the newly combined company. Palo Alto, Calif.-based Essex Woodlands Health Ventures has $2.5 billion under management. Endologix is based in Irvine, Calif.
28 October 2010•6 mins read
